Shares of Medifast (NYSE:MED) were in the red in Tuesday’s after-hours trade as Q4 results showed a significant drop in revenue and profits as the OPTAVIA weight-loss product lost traction among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results